Activation of the clotting system: Heparin-coated versus non coated systems for extracorporeal circulation

International Journal of Artificial Organs

Volumn 20, Issue 12, 1997, Pages 708-712

  Urlesberger, B ^a   Zobel, G ^a   Rodl S ^a   Dacar, D ^a   Friehs, I ^a   Leschnik, B ^a   Muntean, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Animal experiment; Clotting activation; Extracorporeal membrane oxygenation; Heparin coated circuit

Indexed keywords

COAGULATION; OXYGENATION; PLATELETS; POLYSACCHARIDES; RESPIRATORY THERAPY; TIMING CIRCUITS;

ANIMAL EXPERIMENTS; ANTITHROMBIN III; CLOTTING ACTIVATION; COATED SYSTEMS; D DIMERS; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL MEMBRANE OXYGENATION; HEPARIN-COATED CIRCUITS; HEPARINIZATION; LOW DOSE;

CHEMICAL ACTIVATION;

HEPARIN; THROMBIN ANTITHROMBIN COMPLEX;

ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; EXTRACORPOREAL OXYGENATION; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; INTERMETHOD COMPARISON; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; SWINE; THROMBOCYTE COUNT;

EID: 0031424831     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889702001211     Document Type: Article

References (14)

1. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990; 49: 32-4.
2. Borowiec J, Thelin S, Bagge L, Nilson L, et al. Heparin coated circuits reduce activation of granulocytes during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1992; 104: 642-7.
3. Svennevig JL, Geiran OR, Karlsen H, Pederson T, et al. Complement activation during extracorporeal circulation. J Thorac Cardiovasc Surg 1993; 106: 466-72.
4. Motthagy K, Oedeken B, Pöppel K, Bruchmüller, et al. Heparin free long-term extracorporeal circulation using bioactive surfaces. ASAIO Trans 1989; 35: 635-7.
5. Mottaghy K, Oedeken B, Schaich-Lester D, Poppel K, et al. Application of surface with end point attached heparin to extracorporeal circulation with membrane lungs. ASAIO Trans 1989; 35: 146-52.
6. Ovrum E, Brosstad F, Holen E, Tangen G, et al. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass. Circulation 1995; 92: 2579-84.
7. Jones DR, Hill RC, Vasilakis A, Hollingsed MJ, et al. Safe Use of Heparin-coated Bypass Circuits Incorporating a Pump Oxygenator. Ann Thorac Surg 1994; 57: 815-9.
8. Urlesberger B, Zobel G, Zenz W, Kuttnig-Haim M, et al. Activation of the clotting system during extracorporeal membrane oxygenation in full term newborn infants. J Pediatr 1996; 129: 264-8.
9. Koul B, Vesterquist O, Egberg N, Steen S. Twenty-Hour Heparin-Free Veno-Right Ventricular ECMO: An Experimental Study Ann Thorac Surg 1992; 53: 1046-51.
10. Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via modified reducing terminal residue. Biomat Med Dev Art Org 1983; 11: 161-73.
11. Elgue G, Blombäck M, Olsson P, Riesenfeld J. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Thromb Haemost 1993; 70: 289-93.
12. Videm V, Svennevig JL, Fosse E, Semb G, at al. Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations. J Thorac Cardiovasc Surg 1992; 103: 806-13.
13. Knoch M, Köllen B, Dietrich G, Müller E, et al. Progress in veno-venous long-term bypass techniques for treatment of ARDS. Int J Artif Organs 1992; 15: 103-8.
14. Webb AR, Mythen MG, Jacobson D, Mackie IJ. Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation. Intensive Care Med 1995; 21: 84-93.